SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.5%
5Y CAGR+25.1%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+31.5%/yr
Annual compound
5Y CAGR
+25.1%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.56B+83.6%
2024$1.40B+14.6%
2023$1.22B+8.0%
2022$1.13B+26.0%
2021$894.75M+7.0%
2020$836.38M+2.7%
2019$814.22M-